This inventor holds 1 USPTO granted patent. Top assignee: Riken Corporation. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Fumitaka Osakada: Innovator in Retinal Cell Research
Introduction
Fumitaka Osakada is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the area of retinal cell research. His innovative work focuses on methods for producing retinal progenitor cells and photoreceptor precursor cells.
Latest Patents
Fumitaka Osakada holds a patent for a method for induction and differentiation into photoreceptor cells. This invention provides a method of producing primate retinal progenitor cells by culturing primate embryonic stem cells as suspended aggregates in a serum-free medium. The process allows for the obtaining of retinal progenitor cells from the culture. Additionally, the invention outlines a method for producing photoreceptor precursor cells by culturing isolated retinal progenitor cells differentiated from embryonic stem cells under adhesive conditions, in the presence of a gamma secretase inhibitor.
Career Highlights
Osakada is associated with Riken Corporation, a leading research institution in Japan. His work has been instrumental in advancing the understanding of retinal cell differentiation and potential therapeutic applications for vision restoration.
Collaborations
He has collaborated with notable researchers in the field, including Masayo Takahashi and Michiko Mandai. Their joint efforts have contributed to the progress of regenerative therapies for retinal diseases.
Conclusion
Fumitaka Osakada's innovative research and patent contributions are paving the way for advancements in retinal cell therapy. His work holds promise for future treatments aimed at restoring vision and improving the quality of life for individuals with retinal disorders.